Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» edasalonexent
edasalonexent
Catabasis Pharmaceuticals Initiates Ph III Trial for Promising Duchenne Muscular Dystrophy Drug
CP Wire
Tue, 09/25/18 - 11:41 am
Catabasis
edasalonexent
Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals Initiates Ph III Trial for Promising Duchenne Muscular Dystrophy Drug
Tue, 09/25/18 - 10:12 am
Catabasis
edasalonexent
Duchenne Muscular Dystrophy
Catabasis Plans Ph III Trial for Edasalonexent in Duchenne Muscular Dystrophy
CP Wire
Mon, 07/9/18 - 10:51 am
edasalonexent
clinical trials
Duchenne Muscular Dystrophy
Catabasis Plans Ph III Trial for Edasalonexent in Duchenne Muscular Dystrophy
Mon, 07/9/18 - 09:07 am
Catabasis
edasalonexent
Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals' Edasalonexent Slowed Duchenne Muscular Dystrophy Disease Progression Through One Year of Treatment
CP Wire
Thu, 04/26/18 - 09:49 am
Catabasis
Duchenne Muscular Dystrophy
edasalonexent
Catabasis Pharmaceuticals' Edasalonexent Slowed Duchenne Muscular Dystrophy Disease Progression Through One Year of Treatment
Wed, 04/25/18 - 07:40 pm
Catabasis
Duchenne Muscular Dystrophy
edasalonexent
Catabasis Pharmaceuticals Reduces Workforce by 42% to Focus on Developing Edasalonexent for Duchenne Muscular Dystrophy
CP Wire
Wed, 04/18/18 - 09:43 am
Catabasis
Duchenne Muscular Dystrophy
edasalonexent
restructuring
layoffs
Catabasis Pharmaceuticals Reduces Workforce by 42% to Focus on Developing Edasalonexent for Duchenne Muscular Dystrophy
Tue, 04/17/18 - 06:50 pm
Catabasis
Duchenne Muscular Dystrophy
edasalonexent